ShuFen Huang - TTY Biopharm Chief Officer

All Insiders Taiwan . 
Stock . TTY Biopharm Co . Stakeholders . Insider . ShuFen Huang
4105 Stock  TWD 74.40  0.30  0.40%   

Insider

ShuFen Huang is Chief Officer of TTY Biopharm Co
Phone886 2 2652 5999
Webhttps://eng.tty.com.tw

TTY Biopharm Management Efficiency

The company has return on total asset (ROA) of 0.0824 % which means that it generated a profit of $0.0824 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2093 %, meaning that it generated $0.2093 on every $100 dollars invested by stockholders. TTY Biopharm's management efficiency ratios could be used to measure how well TTY Biopharm manages its routine affairs as well as how well it operates its assets and liabilities.
TTY Biopharm Co has accumulated 4.15 M in total debt with debt to equity ratio (D/E) of 19.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. TTY Biopharm has a current ratio of 2.68, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist TTY Biopharm until it has trouble settling it off, either with new capital or with free cash flow. So, TTY Biopharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TTY Biopharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TTY to invest in growth at high rates of return. When we think about TTY Biopharm's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

HuaHsing LiuFounding Construction Developme
N/A
YenFen ChengFounding Construction Developme
N/A
Wen WuTehmag Foods
N/A
YenHui LiuFounding Construction Developme
N/A
Yanfen ZhengFounding Construction Developme
N/A
Wenyao ZhangIbase Gaming
N/A
Ren LiTehmag Foods
N/A
ShuFeng YangChien Kuo Construction
N/A
Yun ZhangHunya Foods Co
N/A
LoFang TsaoFounding Construction Developme
N/A
Changshiou WuChien Kuo Construction
N/A
Hongjie CaiIbase Gaming
N/A
Ssu KungChien Kuo Construction
N/A
Zheng GuoHunya Foods Co
N/A
PaiTso SunChien Kuo Construction
N/A
Jianhua LinIbase Gaming
N/A
Wen HeTehmag Foods
N/A
Zhe WuHunya Foods Co
N/A
TTY Biopharm Company Limited, together with its subsidiaries, produces various pharmaceuticals and chemical drugs in Taiwan and internationally. The company was founded in 1960 and is headquartered in Taipei City, Taiwan. TTY BIOPHARM is traded on Taiwan OTC Exchange in Taiwan. TTY Biopharm Co (4105) is traded on Taiwan OTC Exchange in Taiwan and employs 31 people.

Management Performance

Return On Equity0.21
Return On Asset0.0824

TTY Biopharm Leadership Team

Elected by the shareholders, the TTY Biopharm's board of directors comprises two types of representatives: TTY Biopharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TTY. The board's role is to monitor TTY Biopharm's management team and ensure that shareholders' interests are well served. TTY Biopharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TTY Biopharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
SiYuan Yang, VP
KuoChiang Chang, Corp CFO
ShuFen Huang, Chief Officer
WeiYing Yin, Director Department
JenYang Chang, Chief Officer
ShuWen Wang, Accounting Officer
Allen Chu, Head Unit
ChingLan Hou, G Mang
YungMin Chiang, Internal Officer

TTY Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is TTY Biopharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.21
Return On Asset0.0824
Profit Margin0.24 %
Operating Margin0.26 %
Current Valuation20.05 B
Shares Outstanding248.65 M
Shares Owned By Insiders20.58 %
Shares Owned By Institutions17.40 %
Price To Earning13.04 X
Price To Book3.78 X

Pair Trading with TTY Biopharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TTY Biopharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TTY Biopharm will appreciate offsetting losses from the drop in the long position's value.

Moving together with TTY Stock

  0.741720 Standard ChemicalPairCorr

Moving against TTY Stock

  0.368047 Great ComputerPairCorr
The ability to find closely correlated positions to TTY Biopharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TTY Biopharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TTY Biopharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TTY Biopharm Co to buy it.
The correlation of TTY Biopharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TTY Biopharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TTY Biopharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TTY Biopharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for TTY Stock Analysis

When running TTY Biopharm's price analysis, check to measure TTY Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TTY Biopharm is operating at the current time. Most of TTY Biopharm's value examination focuses on studying past and present price action to predict the probability of TTY Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TTY Biopharm's price. Additionally, you may evaluate how the addition of TTY Biopharm to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY